🇺🇸 FDA

Intelligence Platform

Patents

Browse 7 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10716869

Radiolabeled macrocyclic EGFR inhibitor

Oncodesign SA · Granted Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10676486

Macrocyclic RIP2 kinase inhibitors

Oncodesign SA · Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10377772

Macrocyclic LRRK2 kinase inhibitors

Oncodesign SA · Granted Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9586975

Macrocyclic salt-inducible kinase inhibitors

Oncodesign SA · Granted Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9370519

Macrocyclic FLT3 kinase inhibitors

Oncodesign SA · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9096609

Macrocyclic LRRK2 kinase inhibitors

Oncodesign SA · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9090630

Macrocyclic FLT3 kinase inhibitors

Oncodesign SA · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted